Related references
Note: Only part of the references are listed.Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies
Eduardo Anitua et al.
ACTA OPHTHALMOLOGICA (2015)
Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study
Jose S. Lopez-Garcia et al.
ACTA OPHTHALMOLOGICA (2014)
Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy
Lene Holm Harritshoj et al.
ACTA OPHTHALMOLOGICA (2014)
tTregs, pTregs, and iTregs: similarities and differences
Ethan M. Shevach et al.
IMMUNOLOGICAL REVIEWS (2014)
Therapeutic Potential of Regulatory T cells in Autoimmune Disorders
Johannes Fessler et al.
BIODRUGS (2013)
A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells
Alicia N. McMurchy et al.
BLOOD (2013)
Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response
Samantha L. Bailey-Bucktrout et al.
IMMUNITY (2013)
Allogeneic serum eye drops: time these became the norm?
Krishna G. Badami et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Allogeneic Serum Eye Drops for the Treatment of Dry Eye Patients with Chronic Graft-Versus-Host Disease
Kyung-Sun Na et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Natural regulatory T cells in autoimmunity
Elaine V. Lourenco et al.
AUTOIMMUNITY (2011)
Pathogen Inactivation of Human Serum Facilitates its Clinical Use for Islet Cell Culture and Subsequent Transplantation
Magnus U. Stahle et al.
CELL TRANSPLANTATION (2011)
Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation
M. Stahle et al.
VOX SANGUINIS (2010)
Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect
C-C Chiang et al.
EYE (2009)
Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
Manfred Kunz et al.
MEDIATORS OF INFLAMMATION (2009)
FOXP3 Forkhead Domain Mutation and Regulatory T Cells in the IPEX Syndrome
Eva d'Hennezel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytokines in Sjogren's syndrome
N. Roescher et al.
ORAL DISEASES (2009)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Autologous serum application in the treatment of neurotrophic keratopathy
Y Matsumoto et al.
OPHTHALMOLOGY (2004)
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease
Y Ogawa et al.
BONE MARROW TRANSPLANTATION (2003)
Treatment of recurrent corneal erosions using autologous serum
JMB del Castillo et al.
CORNEA (2002)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
Pathogenesis of acute graft-versus-host disease: Cytokines and cellular effectors
JLM Ferrara
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
The inhibitory effects of transforming growth factor-beta-1 (TGF-β1) in autoimmune diseases
GJ Prud'homme et al.
JOURNAL OF AUTOIMMUNITY (2000)
Share Paper
